Search research articles
Contact Us
Filters
Showing results (151-160 of 596) with videos related to
Page
of 60
Sort By:
Pharmacotherapy
|
January 22, 2021
A guide to therapeutic drug monitoring of β-lactam antibiotics
Andrew J Fratoni, David P Nicolau, Joseph L Kuti
Journal of Clinical Microbiology
|
September 20, 2019
Effect of Clinically Meaningful Antibiotic Concentrations on Recovery of Escherichia coli and Klebsiella pneumoniae Isolates from Anaerobic Blood Culture Bottles with and without Antibiotic Binding Resins
Iris H Chen, David P Nicolau, Joseph L Kuti
Current Medical Research and Opinion
|
June 15, 2007
The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker
Effie L Kuti, William L Baker, C Michael White
Clinics in Chest Medicine
|
August 27, 2011
Optimizing antibiotic pharmacodynamics in hospital-acquired and ventilator-acquired bacterial pneumonia
Seth T Housman, Joseph L Kuti, David P Nicolau
Critical Care Medicine
|
October 11, 2005
Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program
Heather K Sun, Joseph L Kuti, David P Nicolau
Infection Control and Hospital Epidemiology
|
July 9, 2009
Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa
Kathryn J Eagye, Joseph L Kuti, David P Nicolau
The Journal of Infection
|
October 28, 2006
Cefepime pharmacodynamics in patients with extended spectrum beta-lactamase (ESBL) and non-ESBL infections
Su Young Lee, Joseph L Kuti, David P Nicolau
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
May 18, 2025
Quantification of sulbactam and durlobactam in saline and human plasma via ultra-performance liquid chromatography tandem mass spectrometry
Hanna F Roenfanz, David P Nicolau, Joseph L Kuti
Antimicrobial Agents and Chemotherapy
|
November 17, 2021
Erratum for Crandon et al., "Comparative Efficacies of Human Simulated Exposures of Telavancin and Vancomycin against Methicillin-Resistant Staphylococcus aureus with a Range of Vancomycin MICs in a Murine Pneumonia Model"
Jared L Crandon, Joseph L Kuti, David P Nicolau
Antimicrobial Agents and Chemotherapy
|
April 23, 2020
Erratum for Asempa et al., "<i>In Vitro</i> Activity of Imipenem-Relebactam Alone or in Combination with Amikacin or Colistin against Pseudomonas aeruginosa"
Tomefa E Asempa, David P Nicolau, Joseph L Kuti
Page
of 60
Search research articles
Search
Showing results (151-160 of 596) with videos related to
Sort By:
Page
of 60
Pharmacotherapy
|
January 22, 2021
A guide to therapeutic drug monitoring of β-lactam antibiotics
Andrew J Fratoni, David P Nicolau, Joseph L Kuti
Journal of Clinical Microbiology
|
September 20, 2019
Effect of Clinically Meaningful Antibiotic Concentrations on Recovery of Escherichia coli and Klebsiella pneumoniae Isolates from Anaerobic Blood Culture Bottles with and without Antibiotic Binding Resins
Iris H Chen, David P Nicolau, Joseph L Kuti
Current Medical Research and Opinion
|
June 15, 2007
The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker
Effie L Kuti, William L Baker, C Michael White
Clinics in Chest Medicine
|
August 27, 2011
Optimizing antibiotic pharmacodynamics in hospital-acquired and ventilator-acquired bacterial pneumonia
Seth T Housman, Joseph L Kuti, David P Nicolau
Critical Care Medicine
|
October 11, 2005
Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program
Heather K Sun, Joseph L Kuti, David P Nicolau
Infection Control and Hospital Epidemiology
|
July 9, 2009
Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa
Kathryn J Eagye, Joseph L Kuti, David P Nicolau
The Journal of Infection
|
October 28, 2006
Cefepime pharmacodynamics in patients with extended spectrum beta-lactamase (ESBL) and non-ESBL infections
Su Young Lee, Joseph L Kuti, David P Nicolau
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
May 18, 2025
Quantification of sulbactam and durlobactam in saline and human plasma via ultra-performance liquid chromatography tandem mass spectrometry
Hanna F Roenfanz, David P Nicolau, Joseph L Kuti
Antimicrobial Agents and Chemotherapy
|
November 17, 2021
Erratum for Crandon et al., "Comparative Efficacies of Human Simulated Exposures of Telavancin and Vancomycin against Methicillin-Resistant Staphylococcus aureus with a Range of Vancomycin MICs in a Murine Pneumonia Model"
Jared L Crandon, Joseph L Kuti, David P Nicolau
Antimicrobial Agents and Chemotherapy
|
April 23, 2020
Erratum for Asempa et al., "<i>In Vitro</i> Activity of Imipenem-Relebactam Alone or in Combination with Amikacin or Colistin against Pseudomonas aeruginosa"
Tomefa E Asempa, David P Nicolau, Joseph L Kuti
Page
of 60